Table 6: GRADE assessment of certainty of evidence for major molecular biomarkers.
|
Outcome / Biomarker |
No. of Studies |
Study Design |
Risk of Bias |
Inconsistency |
Indirectness |
Imprecision |
Publication Bias |
Overall Certainty |
|
IDH Mutation and Overall Survival |
24 |
Cohort + RCT |
Not Serious |
Not Serious |
Not Serious |
Not Serious |
Undetected |
High ⨁⨁⨁⨁ |
|
1p/19q Codeletion and Overall Survival |
18 |
Cohort + RCT |
Not Serious |
Not Serious |
Not Serious |
Not Serious |
Undetected |
High ⨁⨁⨁⨁ |
|
CDKN2A/B Homozygous Deletion and Overall Survival |
11 |
Cohort Studies |
Serious |
Not Serious |
Not Serious |
Not Serious |
Undetected |
Moderate ⨁⨁⨁◯ |
|
TERT Promoter Mutation and Overall Survival |
13 |
Cohort Studies |
Serious |
Moderate |
Not Serious |
Not Serious |
Possible |
Moderate ⨁⨁⨁◯ |
|
EGFR Amplification and Overall Survival |
9 |
Cohort Studies |
Serious |
Moderate |
Not Serious |
Serious |
Possible |
Low ⨁⨁◯◯ |
|
Chromosome 7 Gain/Chromosome 10 Loss (+7/−10) and Overall Survival |
7 |
Cohort Studies |
Serious |
Moderate |
Not Serious |
Serious |
Possible |
Low ⨁⨁◯◯ |